Velaglucerase Alfa

8 Comments

1. Vikazahn

   01.11.2019

   INDICATION. VPRIV ® (velaglucerase alfa for injection) is a prescription medication indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease.. IMPORTANT SAFETY INFORMATION. Hypersensitivity reactions, including serious allergic reactions (anaphylaxis) have occurred. VPRIV should be administered under the supervision of a healthcare professional.

   Reply
2. Moogukree

   28.10.2019

   Dec 11,  · Velaglucerase alfa is given as an infusion into a vein. A healthcare provider will give you this injection. Velaglucerase alfa is usually given every other week. Follow your doctor's dosing instructions. Velaglucerase alfa must be given slowly, and the infusion can take at least 1 hour to complete. Velaglucerase alfa doses are based on weight.

   Reply
3. Maktilar

   29.10.2019

   Velaglucerase alfa is a gene-activated human recombinant glucocerebrosidase used for the treatment of Type 1 Gaucher disease, caused by a deficiency of the lysosomal enzyme glucocerebrosidase. Additionally, Velaglucerase alfa has also been investigated for use in Type 3 Gaucher disease.

   Reply
4. Nejar

   30.10.2019

   What is velaglucerase alfa? Velaglucerase is a man-made form of an enzyme that occurs naturally in the body. It is used as an enzyme replacement in people with Type I Gaucher disease. Gaucher disease is a genetic condition in which the body lacks the enzyme needed to .

   Reply
5. Faecage

   29.10.2019

   Aug 08,  · VPRIV® (velaglucerase alfa) for Injection. DESCRIPTION. The active ingredient of VPRIV is velaglucerase alfa, which is produced by gene activation technology in a human fibroblast cell line. Velaglucerase alfa is a glycoprotein of amino acids; with a molecular weight of approximately 63 freeppesimpbabbbuckter.evrycontsongvagapawelvenewsmactio.coucerase alfa has the same amino acid sequence as the naturally occurring human .

   Reply
6. Gardagore

   01.11.2019

   Oct 29,  · Velaglucerase alfa, which is produced by gene-activation technology in a human fibroblast cell line, has the same amino-acid sequence as human glucocerebrosidase 5,6,7.

   Reply
7. Takinos

   29.10.2019

   Velaglucerase alfa is an enzyme produced by recombinant DNA technology that is administered as enzyme replacement therapy for the treatment of type I Gaucher's disease. Indications and dose. Type I Gaucher’s disease (specialist use only) By intravenous infusion. For Adult.

   Reply
8. Takasa

   27.10.2019

   VPRIV (velaglucerase alfa for injection) is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease (GD1). 1. Learn more > Resources. Get information about patient programs and .

   Reply